M. D. Anderson Cancer Center's (MDACC) planning and evaluation activities can be grouped into 4 categories: external advisory board (EAB), program reviews, internal planning and review, and program development. External Advisory Board: MDACC has received support from the CCSG to fund an External Advisory Board (EAB) for the past 22 years. In this proposal, funds for planning and evaluation are requested to permit MDACC to continue to convene annually this standing committee of 30 outstanding outside scientific advisors to help plan and evaluate our programs, shared resources and institutional research initiatives. The objectives of the EAB are to: review in-house research programs to evaluate their productivity, excellence, and applicability to institutional goals, identify potential gaps in the scientific activities that might be crucial for development to achieve strategic research objectives, and suggest, at a high level, options to consider for closing these gaps, recommend approaches to develop new research directions, such as the three developing programs described here (Molecular Markers, Molecular Imaging, and Melanoma), and evaluate progress of these new programs, assist in recruiting faculty to the institution by identifying appropriate candidates and evaluating the credentials of applicants for critical programs such as the Trust, evaluate the level of collaboration between basic scientists, clinical scientists, and populationbased investigators and recommend actions to appropriately enhance interactivity between these three areas, and estimate the financial investment necessary for implementation of planned research initiatives. Program Reviews: In addition to the EAB, panels of external peer reviewers are convened to evaluate the quality and progress of selected CCSG programs. We expect to conduct 2-3 reviews annually. Internal Planning and Evaluation: Complementing external reviews are institutional internal research planning and review initiatives. A recent successful internal planning effort was the series of research retreats led by Dr. Mendelsohn during 2006-07 to define major research direction for the next 10 years. Another initiative is the ad hoc program and shared resource reviews conducted by Dr. Bast, VP of translational research and cancer center co-director, Ms. Tektiridis, CCSG executive director, and others as appropriate to the circumstances, to monitor progress in addressing issues identified through external peer reviews, address issues identified in administrative and financial assessments, and to review internal program member and shared resource user feedback. Program Development: Currently, there are three CCSG developing programs, Molecular Markers, Molecular Imaging, and Melanoma, reflective of MDACC's research initiatives in these areas.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
United States
Zip Code
Van Roosbroeck, Katrien; Fanini, Francesca; Setoyama, Tetsuro et al. (2016) Combining anti-miR-155 with chemotherapy for the treatment of lung cancers. Clin Cancer Res :
Cassani, Lisa S; Raju, Gottumukkala S (2016) Techniques for management of bleeding associated with colonic endoscopic mucosal resection. Gastrointest Endosc 83:469-70
Zargar, Homayoun; Atwell, Thomas D; Cadeddu, Jeffrey A et al. (2016) Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol 69:116-28
Ma, Junsheng; Hobbs, Brian P; Stingo, Francesco C (2016) Integrating genomic signatures for treatment selection with Bayesian predictive failure time models. Stat Methods Med Res :
Jinesh, Goodwin G; Kamat, Ashish M (2016) Endocytosis and serpentine filopodia drive blebbishield-mediated resurrection of apoptotic cancer stem cells. Cell Death Discov 2:
Maiti, Abhishek; Cortes, Jorge E; Brown, Yolanda D et al. (2016) Phase I/II study of low-dose azacytidine in patients with chronic myeloid leukemia who have minimal residual disease while receiving therapy with tyrosine kinase inhibitors. Leuk Lymphoma :1-4
Visone, R; Pallante, P; Vecchione, A et al. (2016) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 35:5214
Zhou, Fuling; Li, Ming; Wei, Yongchang et al. (2016) Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells. Oncotarget :
Gamaletsou, Maria N; Rammaert, Blandine; Bueno, Marimelle A et al. (2016) Candida Arthritis: Analysis of 112 Pediatric and Adult Cases. Open Forum Infect Dis 3:ofv207
Parra, Edwin R; Behrens, Carmen; Rodriguez-Canales, Jaime et al. (2016) Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients. Clin Cancer Res :

Showing the most recent 10 out of 9121 publications